Literature DB >> 9269693

Endothelium-dependent vasodilatation and distensibility of large arteries in chronic haemodialysis patients.

C van Guldener1, J Lambert, M J Janssen, A J Donker, C D Stehouwer.   

Abstract

BACKGROUND: Cardiovascular mortality is increased in chronic haemodialysis (HD) patients and is not completely explained by common cardiovascular risk factors. Hyperhomocysteinaemia and chronic HD per se may play a role, because these factors may adversely affect endothelial function and distensibility of conduit arteries, which are important determinants of the risk of atherosclerosis, thrombosis and cardiac hypertrophy.
METHODS: A vessel wall movement detector system was used to investigate endothelium-dependent, flow-mediated and endothelium-independent, glyceryl trinitrate-induced vasodilatation in the brachial artery and compliance and distensibility coefficients (CC and DC) in the common carotid artery in 28 chronic HD patients and 28 control subjects.
RESULTS: Endothelium-dependent, but not endothelium-independent, vasodilatation was markedly reduced in the HD group (3.7 +/- 1.1 vs. 9.7 +/- 1.2%; P = 0.001). The DC was reduced only in a subgroup of patients aged < 50 years: 16.9 +/- 1.5 vs. 22.4 +/- 2.0 10(-3)/kPa (P = 0.032) and was not related to endothelium-dependent vasodilatation. CC did not differ between the groups. Plasma total homocysteine was elevated in the HD patients, but was neither related to endothelium-dependent vasodilatation, nor to DC.
CONCLUSION: Chronic renal failure and (or) chronic haemodialysis are associated with impaired endothelium-dependent vasodilatation, which may reflect an increased susceptibility for the development of atherosclerosis and thrombosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9269693

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  22 in total

1.  Endothelial function predicts positive arterial-venous fistula remodeling in subjects with stage IV and V chronic kidney disease.

Authors:  Christopher D Owens; Nicole Wake; Ji Min Kim; Dirk Hentschel; Michael S Conte; Andres Schanzer
Journal:  J Vasc Access       Date:  2010 Oct-Dec       Impact factor: 2.283

2.  Serum cadmium levels are independently associated with endothelial function in hemodialysis patients.

Authors:  Yuksel Kaya; Elif Ari; Halit Demir; Ilhan Gecit; Ali Beytur; Cigdem Kaspar
Journal:  Int Urol Nephrol       Date:  2011-09-09       Impact factor: 2.370

3.  Abnormalities of endothelial function in patients with predialysis renal failure.

Authors:  J Thambyrajah; M J Landray; F J McGlynn; H J Jones; D C Wheeler; J N Townend
Journal:  Heart       Date:  2000-02       Impact factor: 5.994

Review 4.  Clinical relevance of hyperhomocysteinaemia in atherothrombotic disease.

Authors:  D A Stehouwer
Journal:  Drugs Aging       Date:  2000-04       Impact factor: 3.923

5.  Effect of cholecalciferol on local arterial stiffness and endothelial dysfunction in children with chronic kidney disease.

Authors:  Mehmet Baha Aytaç; Murat Deveci; Kenan Bek; Özlem Kayabey; Zelal Ekinci
Journal:  Pediatr Nephrol       Date:  2015-10-02       Impact factor: 3.714

6.  Cinacalcet may improve oxidative DNA damage in maintenance hemodialysis patients: an observational study.

Authors:  Elif Ari; Yuksel Kaya; Halit Demir; Ebru Asicioglu; Zehra Eren; Eray Celik; Hakki Arikan
Journal:  Int Urol Nephrol       Date:  2014-05-09       Impact factor: 2.370

Review 7.  Homocysteine and blood pressure.

Authors:  Coen van Guldener; Prabath W B Nanayakkara; Coen D A Stehouwer
Journal:  Curr Hypertens Rep       Date:  2003-02       Impact factor: 5.369

8.  Flow-mediated vasodilatation of the brachial artery in children with chronic kidney disease.

Authors:  Amy C Wilson; Elaine Urbina; Sandra A Witt; Betty J Glascock; Thomas R Kimball; Mark Mitsnefes
Journal:  Pediatr Nephrol       Date:  2008-05-06       Impact factor: 3.714

9.  Prognostic predictors and outcomes in patients with abnormal myocardial perfusion imaging and angiographically insignificant coronary artery disease.

Authors:  Fadi Alqaisi; Firas Albadarin; Zehra Jaffery; Leonidas Tzogias; Muath Dawod; Gordon Jacobsen; Karthik Ananthasubramaniam
Journal:  J Nucl Cardiol       Date:  2008-07-31       Impact factor: 5.952

Review 10.  [Atherosclerosis and uremia: signifance of non-traditional risk factors].

Authors:  Walter H Hörl
Journal:  Wien Klin Wochenschr       Date:  2003-04-30       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.